| donepezil / Generic mfg. |
NCT00630851: A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes |
|
|
| Completed | 3 | 249 | Europe | Donepezil (Aricept), Placebo | Pfizer | Alzheimer Disease | | 10/04 | | |
NCT00096473: Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease |
|
|
| Completed | 3 | 229 | US, Canada, Europe, RoW | Donepezil hydrochloride | Eisai Inc., Pfizer | Alzheimer's Disease, Dementia | 06/05 | 09/05 | | |
NCT00165815: The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia |
|
|
| Completed | 3 | | Europe | ARICEPT | Eisai Limited | Dementia With Parkinson's Disease | | 07/05 | | |
NCT00165737: Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease |
|
|
| Completed | 3 | 974 | US | Donepezil Hydrochloride | Eisai Inc. | Dementia, Vascular | 08/05 | 06/06 | | |
NCT00188812: Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease |
|
|
| Completed | 3 | | Canada | donepezil hcl | University Health Network, Toronto, Eisai Inc. | Dementia Associated With Cerebrovascular Disease | | 08/05 | | |
| Completed | 3 | 357 | Europe | Prior Donepezil 5mg, Prior Donzepezil 10mg, Prior Placebo | Eisai Inc. | Parkinson's Disease, Dementia | 07/06 | 07/06 | | |
NCT00174382: Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia |
|
|
| Terminated | 3 | 149 | Canada | Donepezil | Pfizer | Dementia, Vascular, Dementia, Mixed | 04/08 | 04/08 | | |
REFLECT-1, NCT00428090: Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease |
|
|
| Completed | 3 | 862 | US, Europe, RoW | Rosiglitazone | GlaxoSmithKline | Alzheimer's Disease | 09/08 | 09/08 | | |
NCT00754052 / 2016-004948-11: Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 |
|
|
| Terminated | 3 | 8 | US | Aricept (donepezil hydrochloride), Donepezil hydrochloride, Placebo | Eisai Inc., Pfizer | Down Syndrome, Cognitive Dysfunction | 11/08 | 12/08 | | |
| Completed | 3 | 324 | RoW | Shenwu Capsule, Shenwu, Donepezil, Aricept | North China Pharmaceutical Group Corporation | Mild Cognitive Impairment | 05/09 | 05/10 | | |
NCT01245530: An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia |
|
|
| Completed | 3 | 280 | RoW | Aricept, Donepezil HCl, INM-176, KR-WAP-026 | Whanin Pharmaceutical Company | Alzheimer Type Dementia | 02/11 | 03/11 | | |
| Completed | 3 | 1003 | US, Europe, RoW | Dimebon, Placebo comparator | Medivation, Inc., Pfizer | Alzheimer's Disease | 12/11 | 12/11 | | |
NCT01278407: A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase |
|
|
| Completed | 3 | 142 | Japan | Donepezil 5 mg, E2020, Donepezil 10 mg, Donepezil matched placebo | Eisai Co., Ltd. | Dementia With Lewy Bodies (DLB) | 03/13 | 04/13 | | |
NCT01404169: A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease |
|
|
| Completed | 3 | 260 | RoW | E2020, Placebo | Eisai Limited | Alzheimer's Type Dementia | 07/14 | 09/14 | | |
NCT01539031: Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease |
|
|
| Completed | 3 | 351 | Japan | E2020 | Eisai Co., Ltd. | Alzheimer's Type Dementia | 01/15 | 03/15 | | |
| Completed | 3 | 933 | US, Canada, Europe, RoW | Placebo, Idalopirdine | H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. | Alzheimer's Disease | 07/16 | 07/16 | | |
|
| Completed | 3 | 858 | US, Canada, Europe, RoW | Placebo, Idalopirdine, Lu AE58054 | H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. | Alzheimer's Disease | 12/16 | 12/16 | | |
|
| Completed | 3 | 1463 | Canada, US, Europe, RoW | Idalopirdine 60 mg | H. Lundbeck A/S | Alzheimer's Disease | 07/17 | 07/17 | | |
